ResMed Inc. · San Diego, CA United States (NYSE: RMD)
Key ResMed Inc. Financials
| Company Type | Public -(NYSE: RMD) Headquarters |
|---|---|
| Fiscal Year-End | June |
| 2011 Sales (mil.) | $1,243.1 |
| 2011 Employees | 3,450 |
ResMed Inc. Stock Quote (NYSE: RMD)
| Latest 02/15/12 13:46:55 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $29.59 |  0.240 | 0.820 | $29.89 | $29.21 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
ResMed Inc. Income Statement
| Jun 11 | Jun 10 | Jun 09 | |
| Revenue | 1,243.1 | 1,092.4 | 920.7 |
| Cost of Goods Sold | 501.8 | 436.9 | 366.9 |
| Gross Profit | 741.3 | 655.5 | 553.8 |
| Gross Profit Margin | 59.6% | 60% | 60.1% |
| SG&A Expense | 371.2 | 331.9 | 289.9 |
| Depreciation & Amortization | 10.1 | 8.0 | 7.1 |
| Operating Income | 266.9 | 240.4 | 190.3 |
| Operating Margin | 21.5% | 22% | 20.7% |
| Nonoperating Income | 10.7 | 6.2 | 1.2 |
| Nonoperating Expenses | 26.0 | 14.0 | 10.2 |
| Income Before Taxes | 303.7 | 260.6 | 201.7 |
| Income Taxes | 76.7 | 70.5 | 55.2 |
| Net Income After Taxes | 227.0 | 190.1 | 146.4 |
| Continuing Operations | 227.0 | 190.1 | 146.4 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 227.0 | 190.1 | 146.4 |
| Total Net Income | 227.0 | 190.1 | 146.4 |
| Net Profit Margin | 18.3% | 17.4% | 15.9% |
| Diluted EPS from Total Net Income | 1.44 | 1.23 | 0.95 |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
ResMed Inc. Balance Sheet
| Assets | Jun 11 | Jun 10 | Jun 09 |
| Current Assets | |||
| Cash | 735.3 | 488.8 | 415.7 |
| Net Receivables | 283.6 | 232.2 | 214.2 |
| Inventories | 200.8 | 185.6 | 157.4 |
| Other Current Assets | 72.8 | 78.7 | 66.0 |
| Total Current Assets | 1,292.5 | 985.3 | 853.3 |
| Net Fixed Assets | 462.1 | 387.1 | 377.6 |
| Other Noncurrent Assets | 314.4 | 253.9 | 277.1 |
| Total Assets | 2,068.9 | 1,626.4 | 1,508.0 |
| Liabilities | Jun 11 | Jun 10 | Jun 09 |
| Current Liabilities | |||
| Accounts Payable | 55.2 | 57.5 | 48.3 |
| Short-Term Debt | 0.2 | 121.7 | 67.5 |
| Other Current Liabilities | 153.5 | 133.4 | 153.3 |
| Total Current Liabilities | 208.8 | 312.7 | 269.1 |
| Long-Term Debt | 100.0 | 0.0 | 94.2 |
| Other Noncurrent Liabilities | 29.3 | 26.2 | 29.5 |
| Total Liabilities | 338.2 | 338.9 | 392.8 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | 0.0 |
| Common Stock Equity | 1,730.7 | 1,287.5 | 1,115.2 |
| Total Equity | 1,730.7 | 1,287.5 | 1,115.2 |
| Shares Outstanding (thou.) | 151,668.8 | 151,345.4 | 150,502.4 |
All amounts in millions of US Dollars except per share amounts.
ResMed Inc. Cash Flow Statement
| Jun 11 | Jun 10 | Jun 09 | |
| Net Operating Cash Flow | 283 | 188 | 239 |
| Net Investing Cash Flow | (76.5) | (58.3) | (109.3) |
| Net Financing Cash Flow | (79.3) | (61.1) | 1.9 |
| Net Change in Cash | 246.5 | 73.1 | 94.6 |
| Depreciation & Amortization | 10.1 | 8.0 | 7.1 |
| Capital Expenditures | (73.0) | (61.6) | (114.2) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.